19-3192626-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020170.4(NCLN):c.341G>A(p.Arg114Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000821 in 1,582,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020170.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCLN | NM_020170.4 | c.341G>A | p.Arg114Lys | missense_variant | 2/15 | ENST00000246117.9 | NP_064555.2 | |
NCLN | NM_001321463.2 | c.341G>A | p.Arg114Lys | missense_variant | 2/15 | NP_001308392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCLN | ENST00000246117.9 | c.341G>A | p.Arg114Lys | missense_variant | 2/15 | 1 | NM_020170.4 | ENSP00000246117.3 | ||
NCLN | ENST00000590671.5 | c.119G>A | p.Arg40Lys | missense_variant | 2/15 | 2 | ENSP00000466678.1 | |||
NCLN | ENST00000588428.5 | c.185-3557G>A | intron_variant | 5 | ENSP00000467011.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000451 AC: 10AN: 221916Hom.: 0 AF XY: 0.0000325 AC XY: 4AN XY: 123166
GnomAD4 exome AF: 0.00000839 AC: 12AN: 1430708Hom.: 0 Cov.: 32 AF XY: 0.00000565 AC XY: 4AN XY: 708422
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2024 | The c.341G>A (p.R114K) alteration is located in exon 2 (coding exon 2) of the NCLN gene. This alteration results from a G to A substitution at nucleotide position 341, causing the arginine (R) at amino acid position 114 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at